BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26474427)

  • 1. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
    Kim MK; Ye F; Wang D; Cui M; Ward SC; Warner RR; Roayaie S; Shafir M; Schwartz M; Zhang D; Itzkowitz S
    Pancreas; 2016 Apr; 45(4):528-32. PubMed ID: 26474427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors.
    Scott AT; Pelletier D; Maxwell JE; Sherman SK; Keck KJ; Li G; Dillon JS; O'Dorisio TM; Bellizzi AM; Howe JR
    Ann Surg Oncol; 2019 Aug; 26(8):2525-2532. PubMed ID: 31011904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.
    Fotouhi O; Kjellin H; Juhlin CC; Pan Y; Vesterlund M; Ghaderi M; Yousef A; Andersson-Sand H; Kharaziha P; Caramuta S; Kjellman M; Zedenius J; Larsson C; Orre LM
    Oncogene; 2019 Oct; 38(43):6881-6897. PubMed ID: 31406256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.
    Söderquist F; Janson ET; Rasmusson AJ; Ali A; Stridsberg M; Cunningham JL
    PLoS One; 2016; 11(10):e0164354. PubMed ID: 27736994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in gene expression in small bowel neuroendocrine tumors associated with progression to metastases.
    Keck KJ; Breheny P; Braun TA; Darbro B; Li G; Dillon JS; Bellizzi AM; O'Dorisio TM; Howe JR
    Surgery; 2018 Jan; 163(1):232-239. PubMed ID: 29154080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
    Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine.
    Wang YC; Zuraek MB; Kosaka Y; Ota Y; German MS; Deneris ES; Bergsland EK; Donner DB; Warren RS; Nakakura EK
    Endocr Relat Cancer; 2010 Mar; 17(1):283-91. PubMed ID: 20048018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
    Edfeldt K; Hellman P; Westin G; Stalberg P
    BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Treatment of Small Bowel Neuroendocrine Tumors.
    Farley HA; Pommier RF
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):49-61. PubMed ID: 26614368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas.
    Cui T; Tsolakis AV; Li SC; Cunningham JL; Lind T; Öberg K; Giandomenico V
    Eur J Endocrinol; 2013 Feb; 168(2):253-61. PubMed ID: 23184910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
    Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
    Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of small intestinal neuroendocrine tumors and mesenteric fibrosis.
    Blažević A; Iyer AM; van Velthuysen MF; Hofland J; Franssen GJH; Feelders RA; Zajec M; Luider TM; de Herder WW; Hofland LJ
    Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36951556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
    Moris D; Ntanasis-Stathopoulos I; Tsilimigras DI; Vagios S; Karamitros A; Karaolanis G; Griniatsos J; Papalampros A; Papaconstantinou I; Glantzounis GK; Spartalis E; Blazer DG; Felekouras E
    Anticancer Res; 2018 Mar; 38(3):1267-1278. PubMed ID: 29491050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
    Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
    Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors.
    Edfeldt K; Daskalakis K; Bäcklin C; Norlén O; Tiensuu Janson E; Westin G; Hellman P; Stålberg P
    Neuroendocrinology; 2017; 105(2):170-181. PubMed ID: 27829249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusterin expression in gastrointestinal neuroendocrine tumours is highly correlated with location and is helpful in determining the origin of liver metastases.
    Mourra N; Scriva A; Mansiaux Y; Gozlan S; Bennis M; Balaton A
    Histopathology; 2014 Nov; 65(5):642-50. PubMed ID: 24807631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
    Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
    World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences in somatostatin receptor 2 (SSTR2) immunoreactivity is coupled to level of bowel invasion in small intestinal neuroendocrine tumors.
    Fotouhi O; Zedenius J; Höög A; Juhlin CC
    Neuro Endocrinol Lett; 2018 Oct; 39(4):305-309. PubMed ID: 30531706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.
    Barazeghi E; Prabhawa S; Norlén O; Hellman P; Stålberg P; Westin G
    BMC Cancer; 2018 Jul; 18(1):764. PubMed ID: 30045709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and prognostic significance of extramural venous invasion in neuroendocrine tumors of the small intestine.
    Liu Q; Polydorides AD
    Mod Pathol; 2020 Nov; 33(11):2318-2329. PubMed ID: 32514164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.